Stocks in play: Terra Firma Capital Corporation

Offered an update on its ongoing strategic alternative review. In April 2023, the Company retained Cormark Securities Inc. to act as financial advisor to a special committee of independent directors of the Company (the “Special Committee”) in connection with the strategic alternative review. Over the past several months, the Special Committee has worked with Cormark and its legal advisors to explore strategic alternatives that would maximize shareholder value and also attract potential buyers to enhance outcomes for all stakeholders. These efforts included both monetizing non-core assets and engaging with prospective purchasers in connection with a potential sale of the Company. Terra Firma Capital Corporation shares V.TII are trading unchanged at $6.25.

Read:

• Supply Shortage Could Drive Up Uranium Prices

• Novel Mechanisms Leading the Charge in Fight Against Cancer, Opening Door to New Drugs & Therapies

• Significant Oncology Results Set to be Delivered as Oral Presentations at ASCO 2023

• Promising New Cancer Treatment Data to Be Presented at 2023 ASCO Annual Meeting

• Global Lithium Supply Under Pressure as South American Nations Discuss "Lithium OPEC"